SCHEMBL7370459

SCHEMBL7370459

COC(=O)C(=O)c1cc(OC)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.59
MAPT P10636 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TDP1 Q9NUW8 2/20 0.50
POLB P06746 1/20 0.50
ABCC1 P33527 6/20 0.48
ABCB1 P08183 5/20 0.48
EGFR P00533 1/20 0.48
JUN P05412 1/20 0.47
FTO Q9C0B1 1/20 0.46
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.45
DBH P09172 1/20 0.45
TPMT P51580 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8728260 0.87 TTR (0.60) TTRMAPTSMN1; SMN2TDP1POLB
SCHEMBL7371831 0.87 TTR (0.60) TTRMAPTSMN1; SMN2TDP1POLB
SCHEMBL7364695 0.86 TTR (0.54) TTRMAPTSMN1; SMN2TDP1POLB
SCHEMBL7369436 0.86 TTR (0.54) TTRMAPTSMN1; SMN2TDP1POLB
SCHEMBL750055 0.85 TTR (0.61) TTRMAPTSMN1; SMN2TDP1POLB
SCHEMBL7367380 0.85 TTR (0.55) TTRMAPTTDP1FTOLMNA
SCHEMBL5598228 0.83 LMNA (0.66) TTRMAPTSMN1; SMN2TDP1POLB
SCHEMBL3583434 0.83 CA12 (0.66) TTRMAPTSMN1; SMN2TDP1POLB
SCHEMBL31059025 0.83 LMNA (0.66) TTRMAPTSMN1; SMN2TDP1POLB
SCHEMBL31059024 0.83 LMNA (0.66) TTRMAPTSMN1; SMN2TDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed